Boston Scientific to sell market-leading stents in India
The Natick, Mass.-based medical device giant said it's launching the third generation of its market-leading Promus and Taxus drug-eluting stents in a country of more than 1.1 billion people. Company officials say the DES market in India is surging, with an estimated 150,000 stents implanted annually. BSX won regulatory approval for the devices in India last year.